Cargando…

Evoking Highly Immunogenic Ferroptosis Aided by Intramolecular Motion‐Induced Photo‐Hyperthermia for Cancer Therapy

Immunogenic cell death (ICD) through apoptosis or necroptosis is widely adopted to improve the therapeutic effect in cancer treatment by triggering a specific antitumor immunity. However, the tumor resistance to apoptosis/necroptosis seriously impedes the therapeutic effect. Recently, ferroptosis fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chao, Wang, Zaiyu, Jia, Shaorui, Zhang, Yuan, Ji, Shenglu, Zhao, Zheng, Kwok, Ryan T. K., Lam, Jacky W. Y., Ding, Dan, Shi, Yang, Tang, Ben Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981454/
https://www.ncbi.nlm.nih.gov/pubmed/35132824
http://dx.doi.org/10.1002/advs.202104885
Descripción
Sumario:Immunogenic cell death (ICD) through apoptosis or necroptosis is widely adopted to improve the therapeutic effect in cancer treatment by triggering a specific antitumor immunity. However, the tumor resistance to apoptosis/necroptosis seriously impedes the therapeutic effect. Recently, ferroptosis featured with excessive lipid peroxidation is demonstrated capable of bypassing the apoptosis/necroptosis resistance to kill cancer cells. To date, numerous efficient ferroptosis inducers are developed and successfully utilized for sensitizing cancer cells to ferroptosis. Unfortunately, these inducers can hardly generate adequate immunogenicity during induction of ferroptotic cancer cell death, which distinctly attenuates the efficacy of triggering antitumor immune response, therefore leads to unsatisfactory therapeutic effect. Herein, a novel high‐performance photothermal nanoparticle (TPA‐NDTA NP) is designed by exploiting energy via excited‐state intramolecular motion and employed for immensely assisting ferroptosis inducer to evoke highly efficient ICD through ferroptosis pathway. Tumor models with poor immunogenicity are used to demonstrate the tremendously enhanced therapeutic effect endowed by highly enhanced immunogenic ferroptosis in vitro and in vivo by virtue of the NPs. This study sheds new light on a previously unrecognized facet of boosting the immunogenicity of ferroptosis for achieving satisfactory therapeutic effect in cancer therapy.